United Therapeutics Corporation (UTHR)

Market Closed

17 Jul, 20:00

NASDAQ (NGS)

535. 67

+6.62

+1.2513%

22.35B Market Cap

11.96 P/E Ratio

- Div Yield

422,200 Volume

24.04 Eps

$ 529.05

Previous Close

Investors:

Day Range

528.39 543.56

Year Range

272.12 609.35

Want to track UTHR and more in your Portfolio? 🎯

United Therapeutics Corporation Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Heinrich Jansen van Rensburg Fairtree Asset Management (Pty) Ltd.	1,976	$610,375.4	$1.07M	$455,347.4	74.6%
Binnacle Investments Inc. Binnacle Investments Inc.	43	$13,636.91	$23,131.85	$9,494.94	69.63%
Steven Albrecht Curat Global LLC	203	$62,579	$109,203.85	$46,624.85	74.51%
Nicole Reese WPG Advisers LLC	107	$33,693.61	$57,542.46	$23,848.85	70.78%
HFM Investment Advisors LLC HFM Investment Advisors LLC	3	$904.33	$1,613.34	$709.01	78.4%
TFI Towarzystwo Funduszy Inwestycyjnych PZU SA Towarzystwo Funduszy Inwestycyjnych PZU SA	55	$16,954.79	$29,577.9	$12,623.11	74.45%
Winnow Wealth LLC Winnow Wealth LLC	1,824	$890,112	$980,910.72	$90,798.72	10.2%
Boreal Capital Management LLC Boreal Capital Management LLC	40	$16,768	$21,511.2	$4,743.2	28.29%
Bryce Maxwell Westerkirk Capital Inc.	586	$186,577.83	$315,139.08	$128,561.25	68.9%
AAI ABN AMRO Investment Solutions ABN AMRO Investment Solutions	1,889	$935,640.1	$1M	$68,911.21	7.37%
ESL Element Squared LLC Element Squared LLC	4,240	$2.07M	$2.28M	$210,091.79	10.17%
KMA Kristy Michelle Afraimi BAM Wealth Management LLC	744	$369,882.73	$398,743.08	$28,860.35	7.8%